Stada and Xbrane receive approval for Ximluci by John Pinching | Jan 17, 2023 | News | 0 Biosimilar gains MHRA marketing authorisation for use throughout Britain Read More
Stada and Xbrane gain EU approval for biosimilar Ximluci by John Pinching | Nov 11, 2022 | News | 0 Partnership combines Xbrane’s protein-expression system with Stada’s management teams Read More